Differences Between the Mechanism of Action of MDMA, MBDB, and the Classic Hallucinogens. Identification of a New Therapeutic Class: Entactogens
Journal of Psychoactive Drugs October 1, 1986 DOI: 10.1080/02791072.1986.10472362 (opens in new tab) via OpenAlex
Summary
AI-generated from the abstractMDMA, MBDB, and classic hallucinogens have distinct mechanisms of action. MDMA and MBDB produce a unique psychological profile characterized by enhanced empathy and emotional openness, differing from both stimulants and hallucinogens. This profile defines a new therapeutic class called entactogens. The paper argues that entactogens, by their specific neurochemical effects, offer potential for psychotherapy distinct from that of classic hallucinogens or amphetamines.
Study at a glance
| Characteristics | Theoretical or philosophical paper Peer reviewed |
|---|---|
| Topics | MDMA |
| Keywords | Hallucinogen Psychology Identification biology Mechanism biology |
| Citations | 568 |
| Key finding | Proposes that MDMA and MBDB are 'entactogens,' a new therapeutic class distinct from classic hallucinogens and stimulants, based on differences in mechanism of action and subjective effects. |
Abstract
(1986). Differences Between the Mechanism of Action of MDMA, MBDB, and the Classic Hallucinogens. Identification of a New Therapeutic Class: Entactogens. Journal of Psychoactive Drugs: Vol. 18, MDMA: Proceedings of the Conference, pp. 305-313.